SUMMARY OF PRIORITY TRIAL LAUNCH
Belagavi, India, November 6-13, 2022
Training was attended by scientific leaders for the trial, data coordinating center (RTI International) representatives, sponsors (Bill & Melinda Gates Foundation and FNIH), and representatives from all eight Global Network sites participating in the trial.
- Following a ceremonious opening, project manager Renata Hoffstetter provided the general background on the FNIH and its role in collaborating with the NICHD and BMGF on this and other Global Network trials. She reviewed the execution of the grant agreements, annual report requirements, and financial and scientific reporting requirements, and she encouraged frequent communication as well as collaboration in various communication efforts.
- Four-day protocol training included a rundown of the prerequisites, medication procurement, shipment, inclusion and exclusion criteria for enrollment, consent forms, procedure prep, the actual procedure, follow-up forms, data collection, and safety procedures.
- The last day of the training provided an opportunity to tour the research academy, laboratory, and the research hospital and its maternal and neonatal wards where the study enrollment of postpartum mothers will take place. The group observed two exemplary IV iron infusions for postpartum mothers.
- The training ended with a review of next steps, updated timelines, and a presentation of the protocol training completion certificates.
3rd International Conference on Maternal, Newborn, and Child Health
- Leading experts in maternal and child health from around the world assembled to discuss future priority research areas, define key stakeholders, and develop a roadmap for scaling evidence-based interventions to advance maternal and newborn health and prevent morbidity, both nationally and globally.
- Principal investigators presented the most up-to-date research on maternal health studies.
Renata Hoffstetter presented the FNIH’s perspective on key challenges and the FNIH role in bridging the implementation gaps. She encouraged researchers to involve patient advocates and representatives, local health ministries, and key policymakers at the earliest stages of study designs to increase effectiveness, as well as to implement strong and well-organized program administration to produce well-harmonized and high-quality data across multiple study sites.